Cargando…

Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection

Pseudomonas aeruginosa is an opportunistic, Gram-negative pathogen and an important cause of hospital acquired infections, especially in immunocompromised patients. Highly virulent P. aeruginosa strains use a type III secretion system (T3SS) to inject exoenzyme effectors directly into the cytoplasm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardy, Kierra S., Tessmer, Maxx H., Frank, Dara W., Audia, Jonathon P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708460/ https://www.ncbi.nlm.nih.gov/pubmed/34941717 http://dx.doi.org/10.3390/toxins13120880

Ejemplares similares

The Pseudomonas aeruginosa Type III Secretion System Exoenzyme Effector ExoU Induces Mitochondrial Damage in a Murine Bone Marrow-Derived Macrophage Infection Model
por: Hardy, Kierra S., et al.
Publicado: (2022)

Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding
por: Fischer, Axel W., et al.
Publicado: (2017)

Characterization of the ExoU activation mechanism using EPR and integrative modeling
por: Tessmer, Maxx H., et al.
Publicado: (2020)

ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection
por: Hardy, Kierra S., et al.
Publicado: (2022)

Pseudomonas aeruginosa ExoU augments neutrophil transepithelial migration
por: Pazos, Michael A., et al.
Publicado: (2017)

Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia
por: Howell, Heather A., et al.
Publicado: (2013)

The Population Structure of Pseudomonas aeruginosa Is Characterized by Genetic Isolation of exoU+ and exoS+ Lineages
por: Ozer, Egon A, et al.
Publicado: (2019)

Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
por: Subedi, Dinesh, et al.
Publicado: (2018)

Structural Basis of Cytotoxicity Mediated by the Type III Secretion Toxin ExoU from Pseudomonas aeruginosa
por: Gendrin, Claire, et al.
Publicado: (2012)

Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs
por: Sawa, Teiji, et al.
Publicado: (2016)

Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections
por: Foulkes, Daniel M., et al.
Publicado: (2019)

Pseudomonas aeruginosa ExoU-associated virulence in HCT recipients and patients with hematologic malignancies
por: Fontana, Lauren, et al.
Publicado: (2023)

Structure of the Type III Secretion Effector Protein ExoU in Complex with Its Chaperone SpcU
por: Halavaty, Andrei S., et al.
Publicado: (2012)

Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran
por: Azimi, Somayeh, et al.
Publicado: (2016)

Emergence of ST463 exoU-Positive, Imipenem-Nonsusceptible Pseudomonas aeruginosa Isolates in China
por: Zhu, Ying, et al.
Publicado: (2023)

ExoU Activates NF-κB and Increases IL-8/KC Secretion during Pseudomonas aeruginosa Infection
por: de Lima, Carolina Diettrich Mallet, et al.
Publicado: (2012)

Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology
por: Bagayoko, Salimata, et al.
Publicado: (2021)

ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis
por: da Cunha, Luiz Gonzaga, et al.
Publicado: (2015)

High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
por: Horna, Gertrudis, et al.
Publicado: (2019)

Phenotypic and Genomic Comparison of the Two Most Common ExoU-Positive Pseudomonas aeruginosa Clones, PA14 and ST235
por: Fischer, Sebastian, et al.
Publicado: (2020)

Utilizing in silico and in vitro methods to identify possible binding sites of a novel ligand against Pseudomonas aeruginosa phospholipase toxin ExoU
por: Chamberlain, Krista, et al.
Publicado: (2021)

The effector protein ExoY secreted by Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for GTP
por: Voigt, Ulrike, et al.
Publicado: (2011)

The bacterial toxin ExoU requires a host trafficking chaperone for transportation and to induce necrosis
por: Deruelle, Vincent, et al.
Publicado: (2021)

Intoxication of Host Cells by the T3SS Phospholipase ExoU: PI(4,5)P(2)-Associated, Cytoskeletal Collapse and Late Phase Membrane Blebbing
por: Sato, Hiromi, et al.
Publicado: (2014)

Subversion of Mucosal Barrier Polarity by Pseudomonas Aeruginosa
por: Engel, Joanne, et al.
Publicado: (2011)

In the Absence of Effector Proteins, the Pseudomonas aeruginosa Type Three Secretion System Needle Tip Complex Contributes to Lung Injury and Systemic Inflammatory Responses
por: Audia, Jonathon P., et al.
Publicado: (2013)

Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis
por: Machado, Gloria-Beatriz, et al.
Publicado: (2011)

The ADP-Ribosyltransferase Domain of the Effector Protein ExoS Inhibits Phagocytosis of Pseudomonas aeruginosa during Pneumonia
por: Rangel, Stephanie M., et al.
Publicado: (2014)

Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins
por: Belyy, Alexander, et al.
Publicado: (2016)

The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
por: Rangel, Stephanie M., et al.
Publicado: (2015)

Characterization of exo-s, exo-u, and alg virulence factors and antimicrobial resistance in Pseudomonas aeruginosa isolated from migratory Egyptian vultures from India
por: Sharma, Pradeep, et al.
Publicado: (2014)

Correction: The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
por: Rangel, Stephanie M., et al.
Publicado: (2015)

Pseudomonas aeruginosa ExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase
por: Seifert, Roland, et al.
Publicado: (2013)

Pseudomonas aeruginosa Utilizes the Type III Secreted Toxin ExoS to Avoid Acidified Compartments within Epithelial Cells
por: Heimer, Susan R., et al.
Publicado: (2013)

Anchors for Effectors: Subversion of Phosphoinositide Lipids by Legionella
por: Hilbi, Hubert, et al.
Publicado: (2011)

The Role of Pseudomonas aeruginosa ExoY in an Acute Mouse Lung Infection Model
por: Kloth, Christina, et al.
Publicado: (2018)

Subversion of the Endocytic and Secretory Pathways by Bacterial Effector Proteins
por: Weber, Mary M., et al.
Publicado: (2018)

Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates
por: Robinson, Luca A., et al.
Publicado: (2023)

Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study
por: Wagener, Brant M., et al.
Publicado: (2020)

Novel Type III Effectors in Pseudomonas aeruginosa
por: Burstein, David, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hgd5gpljvlnpm1u1v6lsp6nmic